hcplive.com
Marla Dubinsky, MD: Ushering In a New Era of Crohn's Disease Treatment with Mirikizumab
Cure8 flagged this item because the article title and available source metadata connect it to Crohn's disease, Inflammatory bowel disease, Mirikizumab, and IL-23 inhibitor. We do not yet have enough reliable article text to summarize the details.
This may be most useful for Clinicians and Adult patients following Crohn's disease, Inflammatory bowel disease, Mirikizumab, IL-23 inhibitor, and Medications.
What To Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a clinical trial phase 3 related to Crohn's disease, Inflammatory bowel disease, Mirikizumab, and IL-23 inhibitor. Use the original source link for the full details.
Trial findings can depend on who was enrolled, what outcomes were measured, and how long people were followed. The original source has the study details.
